Streetbeat News

Stock Prices

ENFN

JP Morgan analyst Alexei Gogolev has downgraded Enfusion (NYSE:ENFN) from Neutral to Underweight and reduced the price target from $11 to $9.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:47 am

RDY

Dr Reddy's Laboratories (NYSE:RDY) exceeded analyst expectations for Q3, posting earnings of $0.99 per share against the estimated $0.79, a 25.7% beat. Year-over-year, earnings rose by 9.12% from $0.91 per share. Sales reached $866.64M, surpassing estimates by 4.94% and marking a 5.10% increase from the previous year's $824.61M.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:46 am

AMD

Raymond James analyst Srini Pajjuri has downgraded Advanced Micro Devices (AMD) from Strong Buy to Outperform while increasing the price target from $190 to $195.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:42 am

FIVE

Oppenheimer analyst Brian Nagel downgraded Five Below (NASDAQ:FIVE) from Outperform to Perform and reduced the price target from $235 to $200.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:40 am

ETH-USD

Polymarket traders are betting on Donald Trump's victory in the 2024 U.S. presidential election with a 55% probability. Trump's odds increased after winning the first two Republican primaries. Biden's chances stand at 38%, while other candidates like Nikki Haley and Michelle Obama are considered long shots. Polymarket, a decentralized betting platform using Ethereum's blockchain, has seen over $22 million in wagers on the election, with $3.4 million on Trump.

Portfolio Pulse from Mehab Qureshi

January 30, 2024 | 10:39 am

AGFY

I-Tseng Jenny Chan reported a 49.99% stake in Agrify Corporation (AGFY) through a 13D filing on Monday. Following the news, AGFY shares surged 64% in premarket trading.

Portfolio Pulse from Charles Gross

January 30, 2024 | 10:37 am

AAPL

GOOG

META

MSFT

Xreal, a Chinese AR glasses manufacturer, has raised $60 million in funding, surpassing a $1 billion valuation. The company plans to use the funds to expand manufacturing and R&D to meet demand beyond 2024. Xreal is preparing for an IPO within two years and expects revenues of $200-$300 million by 2025. The company competes with Apple, Meta, and Google in the AR market but does not intend to enter the VR space. Xreal captured about 50% of the AR-exclusive device market in Q3 of the previous year.

Portfolio Pulse from Ananya Gairola

January 30, 2024 | 10:36 am

IDXX

Piper Sandler analyst David Westenberg has downgraded IDEXX Laboratories (NASDAQ:IDXX) from Overweight to Neutral and set a price target of $525. This change reflects a revised outlook on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:36 am

BXP

Barclays analyst Anthony Powell has maintained an Equal-Weight rating on Boston Properties (NYSE:BXP) but has reduced the price target from $65 to $64.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:35 am

DIS

Reliance Industries has not commented on rumors of a potential merger with Walt Disney Co's India unit. The speculation arose from reports of advanced discussions to merge media and entertainment operations in India, potentially creating the largest media conglomerate in the country. However, Reliance has remained silent following a recent dispute involving Zee Entertainment and Disney Star, which could lead to a $2-billion valuation downgrade for Disney Star due to financial losses from media rights agreements.

Portfolio Pulse from Utkarsh Roshan

January 30, 2024 | 10:35 am